Breakout
The Next Frontier in Amyloidosis Management: Comprehensive CMR Imaging Strategies for Improved Patient Outcomes
Agenda
Welcome and Introduction
Clinical integration of Cardiac MRI: the UK Academic experience
Clinical integration of Cardiac MRI: Community insights from US
Audience questions and closing remarks
Learning Objectives
Determine the value of cardiac MRI for evaluating cardiac amyloidosis.
Identify CMR features consistent with amyloidosis.
Recall patient characteristics suggestive of amyloidosis and warrant assessment with CMR.
This breakout is sponsored by Circle Cardiovascular Imaging.
IME Symposium
ATTR-CM: Where Are We Now and Where to Next?
Agenda
-
Welcome and Introduction
-
Presentation: Measuring Success in ATTR-CM: Now and in the Future
-
Presentation: Is reversal within reach?
-
Audience questions and closing remarks
Learning Objectives
-
Recall what the current ATTR-CM therapy landscape is in terms of clinical efficacy
-
Quantify the current need to reverse CM disease in terms of progressive disease and mortality rate
-
Describe the process of antibody-mediated disease reversal
This IME symposium is supported by an unrestricted educational grant from AstraZeneca.
